Evidence map›Paper›PMID 12803922›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2003

Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases.

Richard E Pagano

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  11. Review
  12. Glycosphingolipid functions.Cold Spring Harbor perspectives in biology · 2011
    Review
  13. Review
  14. Review
  15. Article
  16. Pathophysiology of neuropathic lysosomal storage disorders.Journal of inherited metabolic disease · 2010
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Richard E PaganoDepartment of Biochemistry and Molecular Biology, Mayo Clinic and Foundation, 200 First Street, SW, Rochester, MN 55905, USA. pagano.richard@mayo.edu
Mayo Clinic · US

Funding

INTRACELLULAR TRANSLOCATION AND METABOLISM OF LIPIDSR01GM022942 · NIGMS · MAYO CLINIC ROCHESTER · PI MARKS, DAVID LARRY · 1985 to 2010
$5.3M
MEMBRANE TRAFFIC IN SPHINGOLIPID STORAGE DISEASESR01GM060934 · NIGMS · MAYO CLINIC ROCHESTER · PI LIMPER, ANDREW H · 2001 to 2011
$2.9M
INTRACELLULAR TRANSLOCATION AND METABOLISM OF LIPIDSR37GM022942 · NIGMS · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI PAGANO, RICHARD E · 1989 to 1998
–
NIGMS NIH HHS GM-22942NIGMS NIH HHS GM-60934
6 · The paper itself

Abstract

In this review, recent studies of membrane lipid transport in sphingolipid (SL) storage disease (SLSD) fibroblasts are summarized. Several fluorescent glycosphingolipid (GSL) analogues are internalized from the plasma membrane via caveolae and are subsequently transported to the Golgi complex of normal fibroblasts, while in 10 different SLSD cell types, these lipids accumulate in endosomes and lysosomes. Additional studies have shown that cholesterol homeostasis is perturbed in multiple SLSDs secondary to accumulation of endogenous SLs, and that mis-targeting of the GSLs is regulated by cellular cholesterol. Golgi targeting of GSLs internalized via caveolae is dependent on microtubules and phosphoinositide 3-kinase(s) and is inhibited by expression of dominant-negative rab7 and rab9 constructs. Overexpression of wild-type rab7 or rab9 (but not rab11) in Niemann-Pick C fibroblasts results in correction of lipid trafficking defects, including restoration of Golgi targeting of fluorescent lactosylceramide and endogenous GM1 ganglioside (monitored by the transport of fluorescent cholera toxin), and a dramatic reduction in accumulation of intracellular cholesterol. These results suggest an approach for restoring normal lipid trafficking in this, and perhaps other, SLSD cell types, and may provide a basis for future therapy of these diseases.

Indexed as

AnimalsEndocytosisGlycosphingolipidsHumansProtein TransportSphingolipidosesGlycosphingolipids

Identifiers

PMID12803922
PMCPMC1693187
OpenAlexW1975229711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.